T0	MultiCitation 4633 4637	[15]
T1	MultiCitation 16896 16900	[15]
T2	Citation 23413 23417	[15]
T3	Span 4442 4642	Recent molecular analyses have added further heterogeneity to breast cancer by identifying a new, claudin-low subtype with poor prognosis comparable to that associated with the basal subtype [15]â€“[17]
R1	Context Target:T0 Context:T3	
T4	Span 4644 4710	However, the origin of claudin-low breast cancers remains unclear.
R2	Context Target:T0 Context:T4	
T5	Span 16838 16906	Using the published claudin-low gene expression signature [15], [17]
R3	Context Target:T1 Context:T5	
T6	Span 23240 23418	Importantly, recent studies have shown that EMT is a feature of the claudin-low subtypes of breast cancers which is associated with poor prognosis and resistance to therapy [15].
R4	Context Target:T2 Context:T6	
